The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
On 2 December 2014, EDCTP opened the first call for research proposals under its second programme.
The call invites proposals for research on validation of the clinical performance and/or implementation of new or improved diagnostic tools and technologies for detection of any of the poverty-related diseases.
On 31 october, EDCTP and WHO-TDR launched a joint call for applications for the Clinical Research and Development Fellowships.
EDCTP is a partnership between Europa and sub-Saharan Africa, a partnership between 13 African and 13 European countries that jointly contribute to the fight against HIV/Aids, tuberculosis, malaria and other neglected infectious diseases.
Find out more about who we are!
EDCTP2 aims to contribute to the reduction of the social and economic burden of poverty-related diseases (PRDs) in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for PRDs in partnership with sub-Saharan Africa.
EC Commissioner Carlos Moedas and Gulbenkian Foundation sign collaboration memorandum
This coincides with the prepublication today of an EDCTP 2015 Call for proposals aimed at strengthening the ethics and regulatory capacity in sub-Saharan Africa….
Preannouncement of 2015 Calls for Proposals
The purpose of this forthcoming call for proposals is to provide funding to projects that aim to evaluate new or…